Extra Extra Read all about it.EWSI at your local brokers on sale for ridiculously low prices. This super low floater is going to the moon and back. We dug up Scottie and reinstated CPT Kirk to pilot this baby. She is going to fly. Hang on and get your tickets now. Even though Scotty is a little stiff we think he can give her more power and rocket this thing to warp factor 4. No doubt there will be luls in the trading day because CPT Kirk will have to promo Price Line @ noon but that only gives us traders fingers a well needed rest. We even had the shields reworked with a special coating to stop shorters from infiltrating. Step right in step right in for the greatest 10 bagger of the year. She has a super low float of only 37.5M. That’s right 37,500,000 float. Now you can’t find that on just any pink can you? She has a chart that only a mother could love. We got a management team with impeccable careers and a plethora of years experience. What more do you want. This company will take your old 8088 Intell and scrap it properly or rebuild it to the fastest quad core AMD on the block. Let me through a plug at you, this company says if it has a plug they will take it so wire up your old hound dog and get ready to make some coin. Ron Propiel couldn’t be here today because he was premiering his new Slagamajab which is the next best thing to EWSI. So don’t let that hold you back because I personally talked to Ron and he reassured me that he will fit us into the schedule next week. Hurry before the float is locked and you miss the boat. Get outta those jammies and get to your broker before it is too late. Retire tomorrow with a small investment today. Don’t let cheap imitations fool you this is the real deal, the one and only EWSI.
Disclaimer: I really never talked to Ron Propiel but I know a friend who once knew a guy that met him in the bathroom at LAX between flights. We really couldn’t exhume Scotty because the family rejected our request and CPT Kirk was to busy and told us to get bent or that might have been the dream I had last night. Ron’s new slagamajab was a figment of my imagination but sounded like something he might be working on. This is all for entertainment purposes and you are requested to do your own DD. I accept no responsibility for your financial losses if you buy this stock and it tanks but I do want 20% of any profits for the tip. Your retina may have been scanned and recorded as an acknowledgment of this disclaimer. This is all brought to you by Hillbilly Stocks, Pigsknuckle , AR. Zip unknown and I sure ain’t gonna tell you the full address. This is all in Bold type so you can read it unlike those sites that put it in 2 point type. Hillbilly Stocks received no monetary or stock compensation for this add. You are on your own Jack.
Posted On: 07/17/2012 7:45:09 AM
Post# of 144097
(0)
(0)
Top 10 Most Recent Blog Posts
Tilray Brands, Inc. (TLRY): A Global Cannabis Leader
Category: Stocks Total Views: 115
By : Kelly Martin Updated: 07-29-2024
Overview of Tilray Brands, Inc.
Tilray Brands, Inc. (NASDAQ: TLRY) is a pioneering company in the field of medical and recreational cannabis production and research. Headquartered in Canada, Tilray has positioned itself as a global leader with a commitment to providing safe, consistent, and reliable therapy to patients and consumers worldwide. The company operates in multiple regions, including Canada, the United States, Europe, Australia, and Latin America, serving a diverse clientele rangin... Continue Reading
Understanding the Demand Generation Process for Business Growth
Category: Business Total Views: 131
By : Ryan Hughes Updated: 07-29-2024
Introduction to Demand Generation
In the fast-paced world of digital marketing and advertising, understanding the demand generation process is crucial for business growth. Demand generation is a comprehensive strategy aimed at creating awareness and interest in a company's products or services, ultimately driving customer engagement and revenue. For advertisers, especially in the realm of connected TV advertising, mastering demand generation can significantly enhance performance marketing... Continue Reading
Philips Unveils New AI Cardiovascular Ultrasound Platform
Category: Stocks Total Views: 128
By : Henry Turner Updated: 07-29-2024
Philips Reports Strong Order Intake Growth in Q2 2024
With a 9% rise over past periods, Philips's order intake in Q2 2024 rose significantly. Mostly, the North American market drove this expansion. With group sales of EUR 4.5 billion, the company said that comparable sales had risen by 2%. Operations brought in EUR 816 million, of which EUR 538 million came from insurance earnings. The changed EBITA margin climbed to 11.1% of sales. Apart from a free cash outflow of EUR 64 million, Philip... Continue Reading
High-Purity Canola Protein: Burcon’s New Achievement
Category: Stocks Total Views: 164
By : Dominic Sanders Updated: 07-29-2024
Burcon NutraScience Achieves Milestone in Canola Protein Production
Leader in plant-based protein technologies, Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) has effectively finished its first end-to-end validation trial for manufacturing high-purity canola protein isolate. For Burcon's goal of releasing creative, plant-based protein solutions onto the market, this success represents a major forward step.
Commercialization of Canola Protein Technology
Burcon's commerc... Continue Reading
Cosa's Orbit Project Gains Untapped Exploration Areas
Category: Stocks Total Views: 163
By : Caleb Price Updated: 07-29-2024
Acquisition of Mineral Claims in Athabasca Basin
Skyharbour Resources LTD. has signed an asset purchase agreement with Cosa Resources Corp. Signed July 26, 2024, the agreement calls for acquiring two mineral claims in the Athabasca Basin, Saskatchewan. With 12,718 hectares, these claims will double the footprint of the Orbit uranium project. With this purchase, Cosa will be able to increase its eight kilometer control of untested strike length. The claims follow trend with uranium mineralizat... Continue Reading
Hyperfast Title Joins reAlpha's AI Homebuying Platform
Category: Stocks Total Views: 194
By : Riley Hayes Updated: 07-29-2024
reAlpha Acquires 85% Stake in Hyperfast Title, LLC
85% of Hyperfast Title, LLC. has been acquired by reAlpha Tech Corp. Hyperfast calls Florida, Virginia, and Tennessee home. This purchase expands the portfolio of reAlpha with title and settlement services. Re Alpha is renowned for creating real estate artificial intelligence technologies. The purchase from Madison Settlement Services fits the expansion plan of reAlpha. This action enhances the homebuying market offerings from reAlpha. The in... Continue Reading
Long-term Projections for AI Technologies Development
Category: Business Total Views: 159
By : Hannah Lewis Updated: 07-29-2024
The Rise of Generative AI: Transforming Industries and Investment Strategies
By allowing the creation of fresh content—text and images as well as music and design—generative artificial intelligence is changing sectors. Companies use this technology to improve operations and boost inventiveness. Generative artificial intelligence creates tailored marketing materials in advertising, so boosting interaction. In the medical field, it helps with new medical imaging creation and drug di... Continue Reading
New Alzheimer's Treatment: Anavex's Blarcamesine Success
Category: Stocks Total Views: 240
By : Addison Perry Updated: 07-29-2024
Anavex Life Sciences Reports Promising Results for Alzheimer's Treatment
From its Phase IIb/III study on blarcamesine (ANAVEX®2-73), a medication for early Alzheimer's disease (AD), Anavex Life Sciences Corp. (Nasdaq: AVXL) has reported encouraging findings. Leading neurology specialist Dr. Marwan Noel Sabbagh delivered the data at the 2024 Alzheimer's Association International Conference (AAIC). Taken once daily, blarcamesine has shown great promise in halting the advance of ... Continue Reading
Windtree's Latest Advances: Istaroxime Clinical Trials
Category: Stocks Total Views: 289
By : Lucas Young Updated: 07-28-2024
Windtree Therapeutics Updates Istaroxime Clinical Development and Trial Data
Providing a thorough update on the clinical and business development of istaroxime, Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology company committed to developing creative therapies for critical diseases, has This first-in-class treatment seeks to raise blood pressure, preserve or increase renal function, and strengthen systolic contraction and diastolic relaxation of the heart. In three Phase 2 trials... Continue Reading
SEC Charges Citron Capital in Multi-Year Fraud Scheme
Category: Investing Total Views: 267
By : Evelyn Baker Updated: 07-28-2024
SEC Charges Andrew Left and Citron Capital in $20 Million Fraud Scheme
Andrew Left and his company, Citron Capital LLC, have been charged with a $20 million fraud by the Securities and Exchange Commission (SEC). They are activists short sellers. The SEC complaint claims Left recommended stock positions using his Citron Research website and social media platform. He said these positions complemented Citron Capital's and his own investments. Left's recommendations, according to the SEC,... Continue Reading